Renovus Capital Partners-backed Red Nucleus, a provider of learning, performance, and process solutions for the life sciences industry, completed the acquisition of Pyxa Systems, a research & development focused software company. Financial terms were not disclosed. "We are thrilled about the addition of Pyxa and DirectusPro to the Red Nucleus family. There is strong overlap with Pyxa’s DirectusPro software and our existing R&D labeling services. We are now able to offer our clients an industry game changer and strong foundation for R&D compliance software via DirectusPro and are excited to roll the product out to our clients," Ian Kelly, Red Nucleus CEO.